Redirect Notice

Looks like you clickedhttps://www.tga.gov.au/media-release/tga-receives-application-increased-dose-glaxosmithklines-covid-19-treatment-sotrovimab-xevudy-ba2-omicron-sublineage

If you do not want to visit that page, you can close this browser tab.